NCT02631720View on ClinicalTrials.gov

CLAD Phenotype Specific Risk Factors and Mechanisms

CompletedOBSERVATIONAL
Enrollment

884

Participants

Timeline

Start Date

December 22, 2015

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Lung TransplantPost Lung Transplantation
Interventions
PROCEDURE

Blood Draw

PROCEDURE

Bronchoscopy

Trial Locations (5)

21205

Johns Hopkins University, Baltimore

27710

Duke University, Durham

44195

Cleveland Clinic, Cleveland

90095

University of California, Los Angeles, Los Angeles

M5G 2N2

University of Toronto, Toronto

All Listed Sponsors
collaborator

Clinical Trials in Organ Transplantation

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02631720 - CLAD Phenotype Specific Risk Factors and Mechanisms | Biotech Hunter | Biotech Hunter